Once an afterthought, the life science/pharma industry now glimmers as a large blip on the hedge fund radar despite shortfall in flu vaccines and Merck headlines partly because aggressive marketing and pricing have made pharmaceutical companies America's most profitable industry.

This being presidential year as well, Richard shares with us about the life science/pharma industry in this capacity as he joins the dots between India, technology and the life science industry.